Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma

Meijie Tian(National Institutes of Health), Javed Khan(Kent State University), John M. Maris(Children's Hospital of Philadelphia), Yong Kim(National Institutes of Health), Katherine E. Masih(National Institutes of Health), Rimas J. Orentas(Capital Caring), Peter M. Sullivan(Cornell University), Peter Azorsa(National Institutes of Health), Jun S. Wei(Center for Cancer Research), Brian Belyea(University of Virginia), Jerry T. Wu(National Cancer Institute), Corinne M. Linardic(Duke University), Nityashree Shivaprasad(National Cancer Institute), Abdelrahman Rahmy(National Institutes of Health), David Milewski(National Cancer Institute), Hsien-Chao Chou(National Cancer Institute), Adam Cheuk(National Institutes of Health), Young Song(University of British Columbia), Poul H. Sorensen(University of British Columbia), Dina Schneider(Lentigen Technology (United States)), G. Tom Brown(National Cancer Institute), Crystal L. Mackall(Parker Institute for Cancer Immunotherapy), Berkley E. Gryder(University School), Dimiter S. Dimitrov(University of Pittsburgh), Hannah Song(University of Wisconsin–Madison), Larry Moses(National Institutes of Health Clinical Center), Boro Dropulić(Heat Biologics (United States)), Jeetendra Kumar(Center for Cancer Research), Steven L. Highfill(National Institutes of Health)
Cell Reports Medicine
September 28, 2023
Cited by 26


Related Papers